According to filings with the U.S. Securities and Exchange Commission, LifeLens Technologies, Inc. is raising up to $23,171,697.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About LifeLens Technologies, Inc.
LifeLens was founded to create simple, commercially viable technologies for high fidelity physiologic monitoring. Imagine the day when a doctor or a patient can look at a single-screen summary of a patient’s physiologic health in real-time or retrospectively for the past week or proactively for the upcoming week. That day is here! ?We can envision that every doctor visit will require monitoring for routine visits as well as during post procedures. We envision remote monitoring for a significant number of chronic conditions for at-risk patients. We hope to disrupt healthcare in a significant way, similar to some of the technological disruptions that have occurred in recent years. Since 2014, we have been quietly developing our breakthrough technologies that we believe will revolutionize physiologic monitoring for patients remotely and in the hospital. We combine our proprietary feather-weight patch and algorithms that we developed before Artificial Intelligence (AI) came into vogue, resulting in the only platform of its kind! For the past several years, we have been testing our system with the U.S. Military. Their personnel have put it through rigorous testing in extremely harsh conditions. Many report, “I forgot I was wearing it!” Medics and leadership like it as it helps keep the troops safe.

To learn more about LifeLens Technologies, Inc., visit https://www.lifelenstech.com/
LifeLens Technologies, Inc. Linkedin Page: https://www.linkedin.com/company/lifelens-technologies-inc/

Contact:
Brent Moen, Chief Financial Officer
267-362-9362

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.